Structure Therapeutics Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Structure Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2022 to Q3 2024.
  • Structure Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.02M, a 224% increase year-over-year.
  • Structure Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $15.1M, a 124% increase year-over-year.
  • Structure Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.19M, a 226% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $15.1M $6.02M +$4.17M +224% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $10.9M $4.2M +$2.49M +147% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.4M $2.74M +$211K +8.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $8.19M $2.1M +$1.48M +237% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $6.72M $1.86M +$1.23M +196% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $5.49M $1.7M +$1.06M +165% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $4.43M $2.53M +$1.91M +309% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.51M $623K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $628K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 $643K Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-11-17
Q1 2022 $620K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.